Pipeline_METiS TechBio

Pipeline
Pipeline
METiS TechBio has established a diversified pipeline spanning therapeutic areas, target organs, and modalities. Nanodelivery materials are expected to have increasingly broad application prospects in the pharmaceutical sector and across a range of other fields in the future.

Pipeline

TA

Pipeline

Modality

Indication

PCC
IIT/IND
Ph1
Ph2
Ph3
NDA
CNS
MTS-004
Small Molecule
PBA

MTS-004
Small Molecule
Dysphagia

Metabolism
MTS-201
Small Molecule
Obesity

MTS-201
Small Molecule
T2D

MTS-201
Small Molecule
MASH

MTS-201
Small Molecule
SBS

Oncology
MTS-105
Biologics
HCC

MTS-107
Biologics
CESC/HNSCC

MTS-108
Biologics
SCLC

Immunology
MTS-109
Biologics
Autoimmune

MTS-118
Biologics
Autoimmune

MTS-128
Biologics
Autoimmune